At the same time, this change does not solve the access problem for Medicare patients and potentially puts more patients at risk of not finding a provider for their therapy. The current Medicare Part B DMEPOS home infusion benefit remains limited in scope, and it still lacks the structure that drives broad provider participation and predictable access for beneficiaries. 

That’s why Congress needs to take the next step and pass the Preserving Patient Access to Home Infusion Act. Members of the House Energy and Commerce Health Subcommittee expressed bipartisan support for this approach when NHIA testified in January, underscoring that the bill would remove barriers by establishing coverage for the full range of professional services that make the benefit function. It would also create access for patients who need IV anti-infectives, regardless of whether an infusion pump is required.

Please contact Congress today and urge your Representative and Senators to support and advance the Preserving Patient Access to Home Infusion Act.